Canaccord Starts Relay Therapeutics (RLAY) at Buy
(Updated - July 16, 2026 9:10 AM EDT)
Canaccord analyst John Newman initiates coverage on Relay Therapeutics (NASDAQ: RLAY) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Canaccord analyst John Newman initiates coverage on Relay Therapeutics (NASDAQ: RLAY) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
